Загрузка...
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
BACKGROUND: Primaquine is the only licensed antimalarial for the radical cure of Plasmodium vivax infections. Many countries, however, do not administer primaquine due to fear of hemolysis in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In other settings, primaquine is given witho...
Сохранить в:
| Опубликовано в: : | PLoS Negl Trop Dis |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5460895/ https://ncbi.nlm.nih.gov/pubmed/28542194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005602 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|